3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
Leukemia, Myeloid, Acute
44
Precursor Cell Lymphoblastic Leukemia-Lymphoma
32
Myelodysplastic Syndromes
25
Recurrence
18
Multiple Myeloma
17
Lymphoma, Non-Hodgkin
14
Lymphoma, B-Cell
14
Lymphoma
14
Leukemia, Lymphocytic, Chronic, B-Cell
13
Ovarian Neoplasms
12
Hematologic Neoplasms
12
Pancreatic Neoplasms
10
Melanoma
10
Leukemia
9
Hodgkin Disease
9
Burkitt Lymphoma
9
Stomach Neoplasms
8
Myeloproliferative Disorders
8
Lymphoma, Large B-Cell, Diffuse
8
Leukemia, Myelogenous, Chronic, BCR-ABL Positive
8
Neoplasms
7
Leukemia, Biphenotypic, Acute
7
Colorectal Neoplasms
7
Triple Negative Breast Neoplasms
6
Neoplasm Metastasis
6
Lymphoma, Mantle-Cell
6
Lymphoma, Follicular
6
Leukemia, Myelomonocytic, Juvenile
6
Leukemia, Myelomonocytic, Chronic
6
Breast Neoplasms
6
Interventions
Biopsy
9
Specimen Handling
8
Magnetic Resonance Spectroscopy
6
duvelisib
5
Cyclophosphamide
5
ruxolitinib
4
Vincristine
4
10-propargyl-10-deazaaminopterin
4
pembrolizumab
3
X-Rays
3
Prednisone
3
Etoposide
3
Doxorubicin
3
tazemetostat
2
sodium-iodide symporter
2
cemiplimab
2
belinostat
2
Photons
2
Peripheral Blood Stem Cell Transplantation
2
Nivolumab
2
Immunoglobulin G
2
Disulfides
2
Cytarabine
2
Bortezomib
2
Azacitidine
2
venetoclax
1
talimogene laherparepvec
1
romidepsin
1
prednylidene
1
pegylated granulocyte colony-stimulating factor
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Lymphoma, T-Cell
×
fludarabine
×
90 days
×
Clear all
No trials found.